Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Barth

Showing results (71-80 of 142) with videos related to

Pageof 15
Sort By:
Cancer Letters|April 19, 2015
Targeted killing of rhabdomyosarcoma cells by a MAP-based human cytolytic fusion proteinHannes Brehm, Dmitrij Hristodorov, Alessa Pardo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 10, 2012
Reduction of activated macrophages after ischaemia-reperfusion injury diminishes oxidative stress and ameliorates renal damageNgwi G Fet, Anette Fiebeler, Uwe Klinge, et al.
Journal of Cancer Research and Clinical Oncology|April 23, 2015
Novel EGFR-specific immunotoxins based on panitumumab and cetuximab show in vitro and ex vivo activity against different tumor entitiesJudith Niesen, Christoph Stein, Hannes Brehm, et al.
BMC Biotechnology|January 26, 2005
Generation of human antibody fragments against Streptococcus mutans using a phage display chain shuffling approachMichael B Kuepper, Michael Huhn, Holger Spiegel, et al.
Biochemical and Biophysical Research Communications|November 18, 2005
Recombinant soluble human Fcgamma receptor I with picomolar affinity for immunoglobulin GAntje Paetz, Markus Sack, Theo Thepen, et al.
International Journal of Cancer|February 14, 2014
Targeted ex vivo reduction of CD64-positive monocytes in chronic myelomonocytic leukemia and acute myelomonocytic leukemia using human granzyme B-based cytolytic fusion proteinsSonja Schiffer, Reinhard Rosinke, Edgar Jost, et al.
International Journal of Molecular Medicine|September 18, 2004
Measurement of antibody-membrane interactions by surface plasmon resonanceAlexander Klimka, Mehmet K Tur, Michael Huhn, et al.
Biomedicines|May 25, 2017
Designing the Sniper: Improving Targeted Human Cytolytic Fusion Proteins for Anti-Cancer Therapy via Molecular SimulationAnna Bochicchio, Sandra Jordaan, Valeria Losasso, et al.
Molecular Cancer Therapeutics|September 16, 2008
Granzyme B-H22(scFv), a human immunotoxin targeting CD64 in acute myeloid leukemia of monocytic subtypesBettina Stahnke, Theo Thepen, Michael Stöcker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2010
Rapid optical imaging of EGF receptor expression with a single-chain antibody SNAP-tag fusion proteinFlorian Kampmeier, Judith Niesen, Alexander Koers, et al.
Pageof 15

Showing results (71-80 of 142) with videos related to

Sort By:
Pageof 15
Cancer Letters|April 19, 2015
Targeted killing of rhabdomyosarcoma cells by a MAP-based human cytolytic fusion proteinHannes Brehm, Dmitrij Hristodorov, Alessa Pardo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 10, 2012
Reduction of activated macrophages after ischaemia-reperfusion injury diminishes oxidative stress and ameliorates renal damageNgwi G Fet, Anette Fiebeler, Uwe Klinge, et al.
Journal of Cancer Research and Clinical Oncology|April 23, 2015
Novel EGFR-specific immunotoxins based on panitumumab and cetuximab show in vitro and ex vivo activity against different tumor entitiesJudith Niesen, Christoph Stein, Hannes Brehm, et al.
BMC Biotechnology|January 26, 2005
Generation of human antibody fragments against Streptococcus mutans using a phage display chain shuffling approachMichael B Kuepper, Michael Huhn, Holger Spiegel, et al.
Biochemical and Biophysical Research Communications|November 18, 2005
Recombinant soluble human Fcgamma receptor I with picomolar affinity for immunoglobulin GAntje Paetz, Markus Sack, Theo Thepen, et al.
International Journal of Cancer|February 14, 2014
Targeted ex vivo reduction of CD64-positive monocytes in chronic myelomonocytic leukemia and acute myelomonocytic leukemia using human granzyme B-based cytolytic fusion proteinsSonja Schiffer, Reinhard Rosinke, Edgar Jost, et al.
International Journal of Molecular Medicine|September 18, 2004
Measurement of antibody-membrane interactions by surface plasmon resonanceAlexander Klimka, Mehmet K Tur, Michael Huhn, et al.
Biomedicines|May 25, 2017
Designing the Sniper: Improving Targeted Human Cytolytic Fusion Proteins for Anti-Cancer Therapy via Molecular SimulationAnna Bochicchio, Sandra Jordaan, Valeria Losasso, et al.
Molecular Cancer Therapeutics|September 16, 2008
Granzyme B-H22(scFv), a human immunotoxin targeting CD64 in acute myeloid leukemia of monocytic subtypesBettina Stahnke, Theo Thepen, Michael Stöcker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2010
Rapid optical imaging of EGF receptor expression with a single-chain antibody SNAP-tag fusion proteinFlorian Kampmeier, Judith Niesen, Alexander Koers, et al.
Pageof 15